SCOTTSDALE, ARIZONA, USA, February 1, 2024 / — Translational Drug Development (TD2), a leading provider of comprehensive preclinical drug development, translational and clinical trial services, is pleased to announce its acquisition of Flow Contract Site Laboratory (FCSL) located in Bothell, Washington. This strategic move strengthens TD2’s oncology ecosystem, enhancing its capabilities in flow cytometry and […]

The International Clinical Cytometry Society holds its 34th annual meeting October 4-8 2019 in Atlanta Georgia.   The 2019 program includes courses on B cell and T/NK Lymphomas, AML and ALL, Primary Immunodeficiency’s, and Assay Quality and Assay Validation presented by Virginia Litwin and Teri Oldaker.

Although FCSL is not attending, we would like to highlight the annual meeting of The American Society of Clinical Oncology (ASCO), May 31-June 4, 2019 in Chicago, Illinois.